News | February 15, 2022
CDSCO recommends EUA for Corbevax in age group 12-18 years
The recommendation has been sent to the DCGI for approval
The recommendation has been sent to the DCGI for approval
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
Parkinson's disease treatment is the first and only carbidopa/levodopa (CD/LD) tablet designed to be divided for precise dosing
It will open new frontier for south-to-south collaboration and innovation transfer
The three prequalified products are manufactured by the originator company, Roche, but the listings should pave the way for more companies coming forward to seek WHO prequalification
The first patient in India treated at Jaslok Hospital and Research Centre, Mumbai Includes the world’s smallest implantable spinal cord stimulator
Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific
The Ayurveda storefront will enhance visibility of unique Ayurveda products from Indian small businesses and D2C brands
GOSTAR's proprietary data set underwent rigorous analysis and large-scale ML model building to predict drug solubility in a recent joint study. X-Chem's RosalindAI delivered superior and actionable results than other similar analyses using well-known publically available datasets
Adds five years of market exclusivity on approval
Subscribe To Our Newsletter & Stay Updated
